Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ALT
#3034
Altimmune, Inc. Common Stock
3.2
9
USD
+1.86%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+1.86%
Mudança mensal
-8.61%
Mudança em 6 meses
-17.34%
Mudança anual
-28.17%
Fechamento anterior
3.2
3
Abrir
3.2
9
Bid
Ask
Mínimo
3.2
9
High
3.2
9
Volume
77
Mercados
Ações
Cuidados de saúde
ALT
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
37.15 M
43.22 M
49.28 M
70.9 M
77.01 M
130.07 M
—
Valuation ratios
Enterprise value
306.79 M
208.61 M
664.84 M
610.7 M
518.34 M
461.48 M
1.34 B
Price to earnings ratio
—
-3.9
-8.64
-6.34
-5.38
-3.61
-14.38
Price to sales ratio
—
85.74
-10.79 K
1 314.92
25.6 K
7 757.46
55.05 K
Price to cash flow ratio
—
-4.83
-11.72
-7.39
-6.41
-4.71
-17.14
Price to book ratio
—
1.9
3.96
2.89
4.14
1.41
3.08
Enterprise value to EBITDA ratio
-5.56
-2.13
-7.56
-6.24
-4.85
-4.42
-13.16
Profitability ratios
Return on assets %
-0.2
-0.44
-0.41
-0.42
-0.68
-0.31
-0.43
Return on equity %
-0.22
-0.49
-0.46
-0.46
-0.77
-0.39
-0.5
Return on invested capital %
-1 240.11
-1 610.96
-1 362.31
-2 511.47
—
-4 444.59
-4 768.99
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-669.5
-2 197.42
129.03 K
-22.52 K
-515.86 K
-230.46 K
-1.42 M
EBITDA margin %
-665.86
-2 184.92
128.29 K
-22.99 K
-533.92 K
-234.73 K
-1.45 M
Net margin %
-599.2
-2 201.43
124.58 K
-20.76 K
-475.29 K
-214.86 K
-1.32 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
19.16
11.17
11.31
17.26
13.11
18.55
72.02
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.05
0.02
-0
0
0
0
0
Solvency ratios
Debt to assets ratio
0.01
0.01
0.03
—
—
0.13
—
Debt to equity ratio
0.02
0.02
0.03
—
—
0.16
—
Long term debt to total assets ratio
0.01
0.01
0.02
—
—
0.12
—
Long term debt to total equity ratio
0.01
0.01
0.02
—
—
0.15
—
Per share metrics
Operating cash flow per share
—
-1.9
-1.33
-1.42
-1.12
-0.77
-0.81
EBIT per share
—
-2.35
-1.87
-1.8
-1.45
-1.07
-1.13
EBITDA per share
—
-2.33
-1.86
-1.84
-1.5
-1.09
-1.15
Total debt per share
—
0.07
0.12
—
—
0.41
—
Cash per share
—
4.61
3.94
3.72
1.86
3.1
9.69
Net current asset value per share
—
4.94
4.11
3.94
1.93
3.16
9.95
Tangible book value per share
—
4.52
3.68
3.65
1.74
2.55
8.49
Working capital per share
—
4.5
3.75
3.71
1.79
2.99
9.39
Book value per share
—
4.82
3.95
3.65
1.74
2.55
8.49
Notícias
Diretor da Altimmune, Gill, compra US$ 31 mil em ações da empresa
Jefferies reitera recomendação de compra para Altimmune e mantém preço-alvo de US$ 28
ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms
Altimmune Stock: Neutral Outlook With Big 2026 Catalysts
ALT Pemvidutide Explained: What Makes It Different in MASH
Truist inicia cobertura da Altimmune com recomendação de compra
H.C. Wainwright eleva preço-alvo da Altimmune com foco em MASH
H.C. Wainwright raises Altimmune stock price target on MASH focus
Altimmune na conferência da Barclays: avançando o potencial da pemvidutida
Altimmune at Barclays Conference: Advancing Pemvidutide’s Potential
Altimmune na conferência da Leerink: avanços estratégicos no tratamento de MASH
Altimmune at Leerink Conference: Strategic Advances in MASH Treatment